Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

GINA VACCARO

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1700960671
CMS profile
258695
Location
COOKEVILLE, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$77,904.73

268 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
Incyte Corporation $38,890.61 59
Astellas Pharma US Inc $26,602.18 25
Partner Therapeutics, Inc. $6,182.65 14
AstraZeneca Pharmaceuticals LP $2,005.52 15
Daiichi Sankyo Inc. $421.77 12
GlaxoSmithKline, LLC. $230.75 11
Regeneron Healthcare Solutions, Inc. $217.47 4
BeOne Medicines USA, Inc. $210.02 5
PFIZER INC. $208.58 9
Gilead Sciences, Inc. $191.60 6
Bayer Healthcare Pharmaceuticals Inc. $191.21 9
Pharmacosmos Therapeutics Inc. $167.29 4
SOBI, INC $158.24 4
Janssen Biotech, Inc. $157.22 8
ABBVIE INC. $134.81 6
Eisai Inc. $125.99 5
Legend Biotech USA Inc. $109.91 3
E.R. Squibb & Sons, L.L.C. $104.67 5
SANOFI US SERVICES INC. $103.00 1
SEAGEN INC. $99.00 1
GENZYME CORPORATION $98.57 4
Merck Sharp & Dohme LLC $93.55 3
Exelixis Inc. $87.22 3
Novartis Pharmaceuticals Corporation $83.06 5
Celgene Corporation $76.46 3
Takeda Pharmaceuticals U.S.A., Inc. $74.86 3
Aveo Pharmaceuticals, Inc. $64.23 2
Fennec Pharmaceuticals, Inc. $51.17 3
Genmab U.S., Inc. $48.73 2
KYOWA KIRIN, INC. $46.59 2
PharmaEssentia USA Corporation $44.55 2
Alexion Pharmaceuticals, Inc. $43.83 2
Geron Corporation $38.68 2
TerSera Therapeutics LLC $37.44 2
Lilly USA, LLC $36.49 2
TAIHO ONCOLOGY, INC. $35.92 2
JAZZ PHARMACEUTICALS INC. $35.29 2
Ipsen Biopharmaceuticals, Inc $34.14 1
Rigel Pharmaceuticals, Inc. $31.50 1
Dendreon Pharmaceuticals LLC $30.85 1
Deciphera Pharmaceuticals Inc. $29.20 1
BeiGene USA, Inc. $27.42 1
Genentech USA, Inc. $26.97 1
PUMA BIOTECHNOLOGY, INC. $23.39 1
EMD Serono, Inc. $22.12 1
Boehringer Ingelheim Pharmaceuticals, Inc. $21.89 1
Novocure Inc. $21.85 1
ADC THERAPEUTICS AMERICA, INC. $20.58 1
Stemline Therapeutics Inc. $20.13 1
Sumitomo Pharma America, Inc. $19.69 1
pharmaand GmbH $17.36 2
Agios Pharmaceuticals, Inc. $16.86 1
ARRAY BIOPHARMA INC $16.20 1
Karyopharm Therapeutics Inc. $15.45 1

Page 6 of 6; records 251–268 of 268 matching records. This page contains 18 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

GINA VACCARO

NPI 1700960671 · CMS profile ID 258695

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

COOKEVILLE, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 6 of 6; records 251–268 of 268 matching records. This page contains 18 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1700960671?year=2025&recipient=provider&page=6#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
GINA VACCARO, NPI 1700960671, CMS profile ID 258695. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 6 of 6; records 251–268 of 268 matching records. This page contains 18 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1700960671?year=2025&recipient=provider&page=6#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). GINA VACCARO, NPI 1700960671, CMS profile ID 258695. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 6 of 6; records 251–268 of 268 matching records. This page contains 18 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1700960671?year=2025&recipient=provider&page=6#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
GINA VACCARO, NPI 1700960671, CMS profile ID 258695, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 6 of 6; records 251–268 of 268 matching records. This page contains 18 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1700960671?year=2025&recipient=provider&page=6#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

268 matching records · $77,904.73 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 268 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 251–268 of 268.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
BeiGene USA, Inc. $27.4202/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202879322 CMS
Eisai Inc. $27.0602/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244480822 CMS
AstraZeneca Pharmaceuticals LP $27.2202/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207187277 CMS
Incyte Corporation $685.0002/06/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1225993089 CMS
TerSera Therapeutics LLC $22.4402/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244056200 CMS
AstraZeneca Pharmaceuticals LP $25.1201/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206240815 CMS
Novartis Pharmaceuticals Corporation $14.4701/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200562965 CMS
Bayer Healthcare Pharmaceuticals Inc. $23.3701/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225867481 CMS
Lilly USA, LLC $19.0201/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186598676 CMS
AstraZeneca Pharmaceuticals LP $24.2401/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207153206 CMS
Bayer Healthcare Pharmaceuticals Inc. $18.0601/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225867496 CMS
Astellas Pharma US Inc $1,387.5001/15/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1238568293 CMS
SOBI, INC $22.8601/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240269785 CMS
Gilead Sciences, Inc. $17.9701/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234549111 CMS
PFIZER INC. $24.5401/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229918414 CMS
Daiichi Sankyo Inc. $26.8801/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197075597 CMS
PharmaEssentia USA Corporation $15.4101/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246822891 CMS
Dendreon Pharmaceuticals LLC $30.8501/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1245011381 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $3,399.01 17
PY2020 $18,151.99 10
PY2021 $13,856.00 7
PY2022 $34,240.89 38
PY2023 $48,258.92 65
PY2024 $52,042.94 140
PY2025 $77,904.73 268

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $457,496.05 6
PY2024 Principal investigator $449,857.43 39
PY2023 Recipient $111.26 1
PY2023 Principal investigator $725,977.74 96
PY2022 Principal investigator $419,119.54 92
PY2021 Principal investigator $966,597.06 108
PY2020 Principal investigator $1,047,546.71 115
PY2019 Principal investigator $482,673.50 126

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

6 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Amgen Inc. $3,000.00 10/24/2025 Non-covered Recipient Entity
THE ONE ONCOLOGY RESEARCH NETWORK LLC
Phase 3 Multicenter, Randomized, Open-label, Active-controlled Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb for Treatment-nave Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301) No dispute reported 06/30/2026 1246649590
Principal investigator 1 PFIZER INC. $10,940.00 04/14/2025 Non-covered Recipient Entity
Providence Cancer Institute
AN OPENLABEL RANDOMIZED PHASE 3 STUDY OF TUCATINIB IN COMBINATION WITH TRASTUZUMAB AND MFOLFOX6 VERSUS MFOLFOX6 GIVEN WITH OR WITHOUT EITHER CETUXIMAB OR BEVACIZUMAB AS FIRSTLINE TREATMENT FOR SUBJECTS WITH HER2 METASTATIC COLORECTAL CANCER No dispute reported 06/30/2026 1228823401
Principal investigator 1 Amgen Inc. $407,738.44 03/25/2025 Non-covered Recipient Entity
TENNESSEE ONCOLOGY PLLC - CHATTANOOGA
Phase 3 Multicenter, Randomized, Open-label, Active-controlled Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb for Treatment-nave Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301) No dispute reported 06/30/2026 1246649135
Principal investigator 1 Amgen Inc. $320.10 03/25/2025 Non-covered Recipient Entity
TENNESSEE ONCOLOGY PLLC
Phase 3 Multicenter, Randomized, Open-label, Active-controlled Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb for Treatment-nave Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301) No dispute reported 06/30/2026 1246649141
Principal investigator 1 PFIZER INC. $32,997.51 02/03/2025 Non-covered Recipient Entity
Providence Cancer Institute
AN OPENLABEL RANDOMIZED PHASE 3 STUDY OF TUCATINIB IN COMBINATION WITH TRASTUZUMAB AND MFOLFOX6 VERSUS MFOLFOX6 GIVEN WITH OR WITHOUT EITHER CETUXIMAB OR BEVACIZUMAB AS FIRSTLINE TREATMENT FOR SUBJECTS WITH HER2 METASTATIC COLORECTAL CANCER No dispute reported 06/30/2026 1228823407
Principal investigator 1 Merck Sharp & Dohme LLC $2,500.00 01/22/2025 Covered Recipient Teaching Hospital
Providence Portland Medical Center
A Phase 3 Randomized Study of Lenvatinib in Combination with Pembrolizumab Versus Standard of Care in Participants with Metastatic Colorectal Cancer Who Have Received and Progressed On or After or Became Intolerant to Prior Treatment No dispute reported 06/30/2026 1232936968